Canadian Ovarian Cancer Biomarker Project Funded with C$5M | GenomeWeb

By Matt Jones

NEW YORK (GenomeWeb News) – Researchers across Canada will use C$5 million (US$4.9 million) in funding from the Terry Fox Research Institute and the Canadian Partnership Against Cancer to create a new validation system for stratifying ovarian cancer patients based on biomarkers and to predict which patients will respond to standard treatments, TFRI said Thursday.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In PNAS this week: statistical approach to examine intra-tumor heterogeneity, new genetic condition called otulipenia, and more.

Blood tests looking for biomarker changes could catch mental illnesses earlier, Newsweek reports.

DNA testing offers Korean adoptees a way to find their birth parents that sidesteps bureaucratic red tape, according to the New York Times.

A National Institutes of Health researcher has filed an Equal Employment Opportunity complaint against the agency, the Washington Post reports.